Generics 5

Biosimilars

Medical devices

Nutraceuticals

Filters

Iloprost manufacturers

5 products found

Filters

5 products found

iloprost

Solution for injection 1 ml amp. 20mcg &100mcg/ml; 0.5 ml amp. 100mcg/ml; 2.5ml amp. 20 mcg/ml

Dossier type
EU CTD
Country of origin
European Union
Dossier status
Ready
GMP approvals
EU GMP
Unavailable markets
Vietnam

Manufacturer #376

A pharmaceutical manufacturer based in the EU that has been active in EU, CIS, Middle East, North America, and Africa selling its products for 40+ years. Key production lines are Rx and OTC. Main therapeutic areas include cardiology, urology, respiratory system, and oncology. The company's production lines are GMP-compliant. Main dosage forms include solids, semi-solid, liquid, and sterile products.

Manufacturer usually replies in 4 days

iloprost

Ampoules, injection 50 mcg / 0.5 ml

Dossier type
EU CTD
Country of origin
European Union
Dossier status
Ready
GMP approvals
EU GMP

Manufacturer #14955

It is part of the pharmaceutical and medicine manufacturing industry and is located in Europe. This site generates more than $300 million in revenue. The corporate family consists of nearly 20 different companies.

Manufacturer usually replies in 5 days

iloprost

Nebuliser solution 10mcg, 20mcg/ml,

Dossier type
EU CTD
Country of origin
European Union
Dossier status
Under Development
GMP approvals
EU GMP
Unavailable markets
Vietnam

Manufacturer #376

A pharmaceutical manufacturer based in the EU that has been active in EU, CIS, Middle East, North America, and Africa selling its products for 40+ years. Key production lines are Rx and OTC. Main therapeutic areas include cardiology, urology, respiratory system, and oncology. The company's production lines are GMP-compliant. Main dosage forms include solids, semi-solid, liquid, and sterile products.

Manufacturer usually replies in 4 days

Want to view all 5 products? Create your free account today!

Iloprost Manufacturers

Markets of interest

Iloprost is a synthetic analog of prostacyclin PGI2 that dilates systemic and pulmonary arterial vascular beds. The substance acts as a vasodilator, hypotensive, antidiuretic, and prolongs bleeding time. Such properties help to antagonize the pathological changes that take place in the small pulmonary arteries of patients with pulmonary hypertension. The substance is available for sale in the form of ampoules, solution for injection, nebulizer solution, tablets, gel, concentrate for solution for infusion, powder for solution for injection/infusion, from manufacturers in various countries including Y. The drug is provided by a wide range of Iloprost suppliers from various countries including the Y, Y, and Y. Mostly due to the availability of raw materials for the manufacturing process and low labor costs, the leading Iloprost manufacturers and distributors are based in India.

Licensing and brand names

Iloprost was first time approved for use in the United States in 2004. The medication was approved by the EMA in the European Union in 2003. The medication is presently approved in many countries and is available in both generic and trade name versions. The medication is marketed under trade names including Ventavis. One of the most popular branded versions of Iloprost is manufactured and supplied by the German pharmaceutical company Flavine. Other manufacturing companies and distributors from European Union, Turkey, have also successfully adapted to the demands of the global marketplace and produce a variant of the drug with Iloprost as an active ingredient.

Target supply price

The wholesale acquisition cost of the medication inhalation solution (10 mcg/mL) is around $4,228 for a supply of 30 milliliters. The retail price of 1 ml of the drug (10 mcg/mL) in Europe reaches 2538.51 EUR. The medication wholesale prices and commercial terms can vary depending on the supplier. The medication wholesale prices and commercial terms can vary depending on the supplier.

Information from manufacturers

We provide a detailed list of the ILOPROSTmanufacturers and suppliers that you are looking for. You can also find the dossier status of ILOPROSTand the GMP approvals of the different variants of the medication. The product description of all ILOPROSTsuppliers contains essential information about the medication you order including clinical data, stability zones, and a list of countries where ILOPROSTis already registered in. Manufacturers also specify the commercial terms of their offers, such as the market for which the offer is intended, deal type, dossier licensing fee, supply price, payment terms as well as delivery terms. Buyers are advised that online sellers may attempt to market fraudulent versions of the generic drug, whereas Pipeline Pharma, through its pre-auditing and quality control procedures ensures that only verified Follicle-stimulating hormone suppliers and distributors enter our online marketplace, offering you a risk-free global B2B pharmaceutical sales platform.